✦ LIBER ✦

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

✍ Scribed by Ken Sato; Hitoshi Takagi; Satoru Kakizaki; Naondo Sohara; Masatomo Mori

Book ID: 106180078
Publisher: Springer Japan
Year: 2006
Tongue: English
Weight: 61 KB
Volume: 41
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-006-1956-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adefovir dipivoxil monotherapy is a suff

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

✍ Ken Sato; Hitoshi Takagi; Satoru Kakizaki; Naondo Sohara; Masatomo Mori 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 199 KB

Extended treatment with lamivudine and a

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ Robert P. Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 309 KB

Increased risk of adefovir resistance in

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy

✍ Yoon-Seon Lee; Dong Jin Suh; Young-Suk Lim; Suk Won Jung; Kang Mo Kim; Han Chu L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Although adefovir dipivoxil (ADV) has a unique profile of delayed and infrequent resistance in treatment-naïve chronic hepatitis B patients, the association of ADV resistance with previous lamivudine (LAM) resistance is not well understood. We compared the emergence of the ADV-resistant mutations rt

Factors contributing to antiviral effect

Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B

✍ Nao Kurashige; Naoki Hiramatsu; Kazuyoshi Ohkawa; Takayuki Yakushijin; Shinichi 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 321 KB

Cost-effectiveness analysis of lamivudin

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B

✍ M. BUTI; M. A. CASADO; J. L. CALLEJA; J. SALMERÓN; J. AGUILAR; M. RUEDA; R. ESTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Early virological suppression is associa

Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B

✍ H. L.-Y. CHAN; V. W.-S. WONG; C.-H. TSE; A. M.-L. CHIM; H.-Y. CHAN; G. L.-H. WON 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB